Kabiven

Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serine, the active ingredients in Kabiven, are an amino acid solution presented as a parenteral solution for injection for intravenous use. It provides essential amino acids to support protein synthesis and metabolic needs in patients requiring parenteral nutrition.

GNH USA supplies Kabiven as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Kabiven is used in clinical situations where parenteral nutrition is required to maintain protein and nitrogen balance. - Inability to receive enteral feeding: provides a complete amino acid profile intravenously to meet nutritional needs. - Postoperative or critically ill state: supports protein synthesis and nitrogen balance during recovery. - Malabsorption or gastrointestinal dysfunction: supplies essential amino acids when intestinal absorption is compromised.

Kabiven may be associated with infusion‑related and metabolic adverse reactions.

Common Side Effects: - Infusion site erythema or pain. - Mild nausea or vomiting. - Transient hyperglycemia. - Electrolyte shifts such as mild hypernatremia.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis). - Metabolic acidosis. - Thrombophlebitis at the catheter site.

When using Kabiven, clinicians should observe several safety measures. - Assess renal function: monitor serum creatinine and urea levels. - Monitor electrolytes: watch for hypernatremia, hyperkalemia, and calcium disturbances. - Check hepatic status: avoid in severe liver failure without adjustment. - Use aseptic technique: ensure sterile handling of the infusion set. - Avoid in patients with known hypersensitivity to any amino acid component. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Kabiven can interact with other therapies that affect electrolyte or metabolic balance.

Major Interactions (Avoid): - High‑dose potassium supplements: risk of hyperkalemia. - Concurrent sodium bicarbonate solutions: may cause precipitation. - Co‑administration with nephrotoxic antibiotics (e.g., aminoglycosides): increased renal risk.

Moderate Interactions (Monitor Closely): - Total parenteral nutrition containing high glucose: monitor blood glucose. - Loop or thiazide diuretics: observe fluid and electrolyte status. - Additional amino acid solutions: avoid duplication and excess nitrogen load.